Skip to main content
Clinical Trials/NL-OMON50389
NL-OMON50389
Completed
Not Applicable

A feasibility study investigating the safety, performance and gastrointestinal transit of the DV3395 device concept in healthy participants. - DV3395 device concept feasibility study.

ovo Nordisk0 sites65 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ovo Nordisk
Enrollment
65
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ovo Nordisk

Eligibility Criteria

Inclusion Criteria

  • 1\.Informed consent obtained before any study\-related activities. Study\-related
  • activities are any procedures that are carried out as part of the study,
  • including activities to determine suitability for the study.
  • 2\. Male or female.
  • 3\. Aged 18\-55 years (both inclusive) at the time of signing informed consent.
  • 4\. Considered to be generally healthy based on the medical history, physical
  • examination, and the results of vital signs, electrocardiogram and clinical
  • laboratory tests performed during the screening visit, as judged by the
  • investigator.
  • 5\. Body mass index between 18\.5 and 29\.9 kg/m2 (both inclusive).

Exclusion Criteria

  • 1\. Any disorder, which in the investigator\*s opinion might jeopardise
  • participant\*s safety or compliance with the protocol.
  • 2\. Presence of any known or suspected clinically significant GI disease or GI
  • disorder (including functional and structural disorders) as judged by the
  • investigator.
  • 3\. Presence of diarrhoea, defined as passage of three or more loose or liquid
  • stools per day (or more frequent passage than is normal for the individual)
  • within 14 days prior to screening or between screening and V2
  • pre\-administration.
  • 4\. Presence of constipation (defined as having \< 3 bowel movements per week,

Outcomes

Primary Outcomes

Not specified

Similar Trials